Magnesium supplementation reduces interleukin-6 levels in metabolic syndrome
Magnes Res
.
2023 Mar 1;36(1):22.
doi: 10.1684/mrh.2023.0511.
Authors
Sophia Kisters
1
,
Klaus Kisters
2
,
Tanja Werner
3
,
Timm Westhoff
4
,
Hans-Georg Predel
5
,
Hannes Reuter
6
Affiliations
1
University Dental Clinic, Cologne.
2
Med. University Policlinic, Münster,, Operasan Dialysis Centre, Herne,, Society for Magnesium Research, Tutzing.
3
Society for Magnesium Research, Tutzing.
4
Med. Clinic 1, Marienhospital, Herne, Ruhr University, Bochum.
5
Institute of Cardiovascular Research and Sport Medicine, German Sport University, Cologne.
6
Dpt. of Internal Medicine and Cardiology, EVK Köln Weyertal, Cologne and, University Hypertension Center, University of Cologne, Germany.
PMID:
37605602
DOI:
10.1684/mrh.2023.0511
No abstract available
MeSH terms
Dietary Supplements
Humans
Interleukin-6
Magnesium / therapeutic use
Metabolic Syndrome* / drug therapy
Nutrition Therapy*
Substances
Interleukin-6
Magnesium